Want to see TSE:BCT full AI Analyst Report?
BriaCell Therapeutics (BCT) Income Statement
BriaCell Therapeutics Income Statement
Last quarter (Q4 2026), BriaCell Therapeutics's total revenue was $0.00. In Q4, BriaCell Therapeutics's net income was $-12.13M. See BriaCell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jul 26 | Jul 25 | Jul 24 | Jul 23 | Jul 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -121.09K | $ -107.93K | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 36.46M | $ 27.43M | $ 33.33M | $ 23.27M | $ 15.29M | |
| Depreciation and Amortization | $ 121.09K | $ 107.93K | $ 83.90K | $ 15.27K | $ 15.27K |
| $ -36.46M | $ -27.43M | $ -4.85M | $ -23.26M | $ -26.82M | |
| $ -36.58M | $ -27.54M | $ -33.33M | $ -23.27M | $ -15.29M | |
| $ 739.66K | $ 656.60K | $ 28.40M | $ 2.97M | $ -11.55M | |
| $ -35.84M | $ -26.88M | $ -4.93M | $ -20.30M | $ -26.84M | |
| $ -35.42M | $ -26.63M | $ -4.79M | $ -20.30M | $ -26.84M | |
| Per Share Metrics | |||||
| Basic EPS | $ -7.07 | $ -62.95 | $ -43.68 | $ -195.00 | $ -259.50 |
| Diluted EPS | $ -7.07 | $ -62.95 | $ -43.68 | $ -195.00 | $ -259.50 |
| Weighted Average Shares Outstanding | 5.01M | 423.11K | 109.70K | 104.13K | 103.29K |
| Weighted Average Shares Outstanding (Diluted) | 5.01M | 423.11K | 109.70K | 104.13K | 103.29K |
Currency in USD